Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.38 -0.02 (-4.51%)
As of: Oct 22, 2026 · 9:47 AM EDT

Citius Pharmaceuticals (CTXR) Other financing activities (2026)

Updated

Citius Pharmaceuticals' Other financing activities came in at $723,299 for fiscal Q3 2026 (quarter ended Jun 30, 2026).

Analysis

Citius Pharmaceuticals (CTXR) Other financing activities (2026) Analysis & Trends

For FY2019 (ended Sep 30, 2019), Citius Pharmaceuticals' Other financing activities was -$54,926.

  • Going back by fiscal year, Other financing activities was $64,801 in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,155.80 Bn 1,124.39 Bn 19.71 Bn
2 Johnson & Johnson 630.65 Bn 549.18 Bn 17.26 Bn
3 AbbVie 502.74 Bn 475.85 Bn 12.70 Bn
4 Merck 375.34 Bn 329.72 Bn 12.21 Bn
5 Novartis Ag 301.36 Bn 265.35 Bn 11.24 Bn
6 Astrazeneca 265.02 Bn 238.70 Bn 12.86 Bn
7 Amgen 239.16 Bn 194.55 Bn 7.24 Bn
8 Gilead Sciences 192.63 Bn 166.82 Bn 6.22 Bn
9 Pfizer 171.82 Bn 118.47 Bn 10.94 Bn
10 Citius Pharmaceuticals 9.81 Mn -23.76 Mn 1.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -723,299.00
API Access

Citius Pharmaceuticals Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=CTXR&period=max&api_key=YOUR_API_KEY